Location History:
- Seeshaupt, DE (2001)
- Huglfing, DE (2002)
Company Filing History:
Years Active: 2001-2002
Title: Ruediger Rueger: Innovator in Retroviral Research
Introduction
Ruediger Rueger is a notable inventor based in Huglfing, Germany. He has made significant contributions to the field of retroviral research, holding a total of 2 patents. His work focuses on innovative methods for detecting bacteria and enhancing retroviral vector production.
Latest Patents
Ruediger Rueger's latest patents include a groundbreaking invention titled "Amphotropic retrovirus packaging cell line, process for its production and use thereof." This patent describes a method to achieve a titer of retroviral vectors of at least about 10 colony-forming units/ml in cell culture supernatants. The invention utilizes an amphotropic retroviral packaging cell line that integrates functional gag, pol, and env genes into its genome, allowing for independent regulation of gene expression.
Another significant patent is the "Method for the genus-specific or/and species-specific detection of bacteria in a sample liquid." This method involves hybridizing bacterial RNA with a primer that is complementary to specific regions of the RNA of particular bacteria. The process includes elongation in the presence of a suitable polymerase and the detection of the hybridization product through oligonucleotide labeling.
Career Highlights
Throughout his career, Ruediger Rueger has worked with prominent companies in the biotechnology sector, including Roche Diagnostics GmbH and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in retroviral research and bacterial detection methods.
Collaborations
Ruediger Rueger has collaborated with esteemed colleagues such as Wolfgang Ludwig and Karl-Heinz Schleifer. These partnerships have further enriched his research and development efforts in the field.
Conclusion
Ruediger Rueger's innovative work in retroviral research and bacterial detection has established him as a significant figure in the scientific community. His patents reflect his commitment to advancing technology in these critical areas.